Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 4 | 2013 | 871 | 0.530 |
Why?
|
| Bronchiolitis, Viral | 3 | 2011 | 37 | 0.520 |
Why?
|
| Patient Admission | 4 | 2023 | 220 | 0.510 |
Why?
|
| Hypotonic Solutions | 1 | 2014 | 16 | 0.490 |
Why?
|
| Isotonic Solutions | 1 | 2014 | 46 | 0.480 |
Why?
|
| Child, Hospitalized | 1 | 2014 | 62 | 0.470 |
Why?
|
| Respiratory Syncytial Virus Infections | 5 | 2011 | 427 | 0.460 |
Why?
|
| Hyponatremia | 1 | 2014 | 82 | 0.440 |
Why?
|
| Fluid Therapy | 1 | 2014 | 182 | 0.440 |
Why?
|
| Triage | 3 | 2023 | 252 | 0.360 |
Why?
|
| Apnea | 1 | 2009 | 30 | 0.350 |
Why?
|
| Intensive Care Units, Pediatric | 3 | 2019 | 441 | 0.290 |
Why?
|
| Critical Care | 3 | 2022 | 770 | 0.260 |
Why?
|
| Albinism, Oculocutaneous | 1 | 2004 | 1 | 0.260 |
Why?
|
| Nystagmus, Congenital | 1 | 2004 | 3 | 0.260 |
Why?
|
| Bronchiolitis | 3 | 2015 | 126 | 0.260 |
Why?
|
| Patient Discharge | 2 | 2019 | 661 | 0.250 |
Why?
|
| Infant, Premature | 1 | 2009 | 787 | 0.240 |
Why?
|
| Oculomotor Muscles | 1 | 2004 | 179 | 0.230 |
Why?
|
| Hospitalization | 5 | 2023 | 2083 | 0.230 |
Why?
|
| Pediatrics | 2 | 2022 | 1141 | 0.200 |
Why?
|
| Hospitalists | 1 | 2022 | 57 | 0.200 |
Why?
|
| Pneumonia | 2 | 2018 | 751 | 0.180 |
Why?
|
| Hospitals | 1 | 2023 | 485 | 0.170 |
Why?
|
| Length of Stay | 2 | 2015 | 1900 | 0.160 |
Why?
|
| Child | 12 | 2023 | 29154 | 0.150 |
Why?
|
| Community-Acquired Infections | 2 | 2018 | 285 | 0.140 |
Why?
|
| Continuity of Patient Care | 1 | 2018 | 225 | 0.130 |
Why?
|
| Bacterial Typing Techniques | 1 | 2015 | 139 | 0.130 |
Why?
|
| Oximetry | 1 | 2015 | 172 | 0.120 |
Why?
|
| Infant | 10 | 2019 | 13310 | 0.120 |
Why?
|
| Mycoplasma pneumoniae | 1 | 2013 | 13 | 0.110 |
Why?
|
| Nebulizers and Vaporizers | 2 | 2010 | 70 | 0.110 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 502 | 0.110 |
Why?
|
| Severity of Illness Index | 4 | 2013 | 4320 | 0.110 |
Why?
|
| Child, Preschool | 7 | 2018 | 16273 | 0.100 |
Why?
|
| Bacterial Toxins | 1 | 2013 | 228 | 0.100 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 918 | 0.100 |
Why?
|
| Infusions, Intravenous | 1 | 2014 | 1382 | 0.100 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2010 | 26 | 0.090 |
Why?
|
| United States | 5 | 2023 | 15433 | 0.090 |
Why?
|
| Health Status | 1 | 2013 | 590 | 0.090 |
Why?
|
| Risk | 1 | 2014 | 1972 | 0.090 |
Why?
|
| Risk Assessment | 2 | 2014 | 6869 | 0.080 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 1303 | 0.080 |
Why?
|
| Vocal Cords | 1 | 2009 | 90 | 0.080 |
Why?
|
| Delphi Technique | 2 | 2019 | 210 | 0.080 |
Why?
|
| Cough | 1 | 2009 | 116 | 0.080 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2009 | 105 | 0.080 |
Why?
|
| Environment | 1 | 2009 | 190 | 0.080 |
Why?
|
| Forced Expiratory Volume | 1 | 2009 | 314 | 0.080 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2009 | 118 | 0.080 |
Why?
|
| Allergens | 1 | 2009 | 247 | 0.080 |
Why?
|
| Bacterial Infections | 1 | 2011 | 479 | 0.080 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2009 | 273 | 0.080 |
Why?
|
| Cohort Studies | 4 | 2018 | 9244 | 0.070 |
Why?
|
| Humans | 20 | 2023 | 261506 | 0.070 |
Why?
|
| Environmental Exposure | 1 | 2009 | 288 | 0.070 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 1029 | 0.070 |
Why?
|
| Cost of Illness | 1 | 2009 | 498 | 0.070 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2009 | 544 | 0.070 |
Why?
|
| Macrophage Inflammatory Proteins | 2 | 2005 | 34 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 2992 | 0.060 |
Why?
|
| Head Movements | 1 | 2004 | 31 | 0.060 |
Why?
|
| Eye Movements | 1 | 2004 | 116 | 0.060 |
Why?
|
| Electrophysiology | 1 | 2004 | 333 | 0.060 |
Why?
|
| Interleukin-18 | 1 | 2004 | 100 | 0.060 |
Why?
|
| Adolescent | 6 | 2023 | 31252 | 0.060 |
Why?
|
| Posture | 1 | 2004 | 215 | 0.060 |
Why?
|
| Physician-Patient Relations | 1 | 2009 | 792 | 0.060 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2004 | 177 | 0.060 |
Why?
|
| Infant, Newborn | 4 | 2011 | 8223 | 0.060 |
Why?
|
| Patient Acuity | 1 | 2023 | 72 | 0.060 |
Why?
|
| Emergency Service, Hospital | 2 | 2023 | 1148 | 0.060 |
Why?
|
| Interleukin-12 | 1 | 2004 | 253 | 0.060 |
Why?
|
| Quality of Life | 2 | 2013 | 4532 | 0.050 |
Why?
|
| Prevalence | 1 | 2009 | 3260 | 0.050 |
Why?
|
| Syndrome | 1 | 2004 | 1351 | 0.050 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2001 | 171 | 0.050 |
Why?
|
| Visual Acuity | 1 | 2004 | 873 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 4744 | 0.050 |
Why?
|
| Interferon-gamma | 1 | 2004 | 1144 | 0.050 |
Why?
|
| Respiratory Tract Infections | 1 | 2004 | 437 | 0.040 |
Why?
|
| Male | 10 | 2018 | 123000 | 0.040 |
Why?
|
| Inservice Training | 1 | 2019 | 78 | 0.040 |
Why?
|
| Incidence | 1 | 2009 | 5673 | 0.040 |
Why?
|
| Advisory Committees | 1 | 2019 | 203 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 2403 | 0.040 |
Why?
|
| Stakeholder Participation | 1 | 2018 | 38 | 0.040 |
Why?
|
| Patient Transfer | 1 | 2019 | 137 | 0.040 |
Why?
|
| Female | 10 | 2018 | 141928 | 0.040 |
Why?
|
| Hospitals, Community | 1 | 2018 | 79 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2009 | 9180 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 8865 | 0.040 |
Why?
|
| Influenza, Human | 1 | 2005 | 925 | 0.040 |
Why?
|
| Oxygen | 2 | 2015 | 754 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2013 | 12873 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 860 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2009 | 14889 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2019 | 795 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 435 | 0.030 |
Why?
|
| Chemokine CCL4 | 2 | 2005 | 63 | 0.030 |
Why?
|
| Chemokine CCL3 | 2 | 2005 | 63 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2019 | 37905 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2018 | 773 | 0.030 |
Why?
|
| Breath Tests | 1 | 2013 | 177 | 0.030 |
Why?
|
| Chemokine CCL2 | 2 | 2005 | 203 | 0.030 |
Why?
|
| Risk Factors | 1 | 2009 | 17523 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 2013 | 347 | 0.030 |
Why?
|
| Meningitis, Bacterial | 1 | 2011 | 89 | 0.020 |
Why?
|
| Bacteria | 1 | 2015 | 611 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2015 | 2316 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 1021 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 2139 | 0.020 |
Why?
|
| Logistic Models | 1 | 2015 | 3441 | 0.020 |
Why?
|
| Caregivers | 1 | 2013 | 677 | 0.020 |
Why?
|
| Urinary Tract Infections | 1 | 2011 | 321 | 0.020 |
Why?
|
| Bacteremia | 1 | 2011 | 689 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6207 | 0.020 |
Why?
|
| Chemokine CCL5 | 1 | 2005 | 71 | 0.020 |
Why?
|
| Exudates and Transudates | 1 | 2004 | 52 | 0.020 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2004 | 211 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 5687 | 0.010 |
Why?
|
| Nasopharynx | 1 | 2001 | 119 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2001 | 257 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2001 | 250 | 0.010 |
Why?
|
| Adult | 1 | 2004 | 77950 | 0.010 |
Why?
|
| Cytokines | 1 | 2001 | 2809 | 0.010 |
Why?
|